A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead-Sponsored Trials in Subjects with Chronic Hepatitis C Infection

ID Number 12-0534

Principal Investigator(s)
Ponni Perumalswami

Department(s) or Division(s)
Liver Diseases


The purpose of this study is to continue to evaluate the subjects HCV infection after they have completed participation in a Gilead-sponsored treatment study for hepatitis C. Subjects may qualify to take part in this research study, because they have previously participated in a Gilead-sponsored study for treating chronic hepatitis C (HCV) infection. During their participation in the treatment study the hepatitis C virus was still found in their blood.

This study is a long term follow-up to continue to evaluate their HCV infection. No study medication will be administered. Their participation in this research study is expected to last up to 3 years. The number of people expected to take part in this research study at this site is 10.

Contact Information
Shanti Mangar
(212) 241-0493

Recruiting Patients: No